CD34+ Cell Dose, Measurable Residual Disease, and Outcome After Myeloablative HLA-Matched Peripheral Blood Hematopoietic Cell Transplantation for Adults with Acute Myeloid Leukemia
CD34+细胞剂量、可测量的残留疾病以及成人急性髓系白血病患者接受清髓性HLA匹配外周血造血干细胞移植后的预后
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17142323
Gang, Margery; Othus, Megan; Olix, Anne-Chloe; Markey, Kate A; Stirewalt, Derek L; Connelly-Smith, Laura S; Lee, Stephanie J; Milano, Filippo; Walter, Roland B
